Nine months into the SARS-CoV-2 crisis, the situation is looking very different across the globe. In Europe and the US, the second or third waves are really taking effect as winter approaches. In Southeast Asia, Australia, and New Zealand, it is almost COVID-19-free. New Zealand has been a remarkable success story, while Australia had a second wave in the state of Victoria, which was markedly worse than the first, but is now under control with fewer than 10 new cases reported each day. In these countries, rapid and strict lockdowns combined with an inclination of governments to listen to scientists and implement extensive testing regimes appear to be part of the success. The focus on testing highlights the need for access to new, high quality, rapid analytical methods that can reliably detect the virus. If these analytical methods are to be used in the field, then it is expected that they would conform to the ASSURED principle (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free, and Deliverable to end users) outlined by the World Health Organisation. With infectious samples, such as samples containing SARS-CoV-2, expanding to the REASSURED principle (where R is Real time connectivity and E is Ease of specimen collection) is particularly relevant. It is remarkable that the news coverage of COVID-19 has taken terminology that was once the domain of analytical chemistry into everyday speech in the general population. Suddenly, friends and family are asking us about testing rates, throughput, false positives, false negatives, and the purpose of each type of diagnostic test. Similarly, as new understanding about COVID-19 is released, the general public is now scrutinizing the information and its reliability based on whether it has been peer-reviewed or not. In both Analytical Chemistry and ACS Sensors, we strive to publish papers in which the analytical method is fit-for-purpose, and thus feel that the papers we publish will not only be of interest to academic researchers coming up with conceptual advances, but also to researchers in industry seeking to commercialize diagnostic methods. We hypothesized that if researchers in industry are reading papers in Analytical Chemistry and ACS Sensors, then one could also expect that they will be publishing papers in these journals. Public awareness that peer review is a signature of quality means that high-technology commercial organizations are keen to publish once intellectual property is protected. Peer-reviewed, published research is indeed one of the best advertising documents a company can get. So, the question is, are industry-based researchers publishing in ACS Sensors and Analytical Chemistry? The answer is an undeniable yes, and at an increasing rate. In this virtual issue, we showcase some of the outstanding papers recently published with industry-based researchers in the author list. In some of these papers, academic researchers are driving the research, with industry scientists as middle authors helping direct the research. In other papers, the industry researchers are the lead authors, and some papers have an author list comprised solely of industry-based researchers. The types of companies we’ve seen represented in the papers published recently in ACS Sensors and Analytical Chemistry span from small university start-up companies to small-to-medium enterprises to massive multinationals. The science itself is also incredibly diverse—from significant improvements on well-known sensing concepts, such as lateral flow devices, to completely new analytical concepts. The breadth of these papers really does emphasize the incredible research into diagnostic methods being performed both in universities and in industry, and highlights the benefits of collaboration between the two. Such collaboration looks to be a big part of our future as governments start to think about economic recovery post-SARS-CoV-2. The signs are that governments are really going to push for more translational research and more local (or sovereign) manufacturing. From our perspective at ACS Sensors and Analytical Chemistry, we are reassured by seeing significant contributions from industry, that the papers we publish encourage researchers from industry not only to read the journals, but also to publish in them. Views expressed in this editorial are those of the authors and not necessarily the views of the ACS. This article has not yet been cited by other publications.

中文翻译：

---

传感器与行业虚拟问题

进入SARS-CoV-2危机已有9个月了，全球情况看起来大不相同。在欧洲和美国，随着冬季的临近，第二波或第三波确实开始生效。在东南亚，澳大利亚和新西兰，它几乎不含COVID-19。新西兰是一个了不起的成功故事，而澳大利亚在维多利亚州发生了第二波热潮，虽然明显比第一波还差，但现在受到控制，每天报告的新病例少于10例。在这些国家/地区，快速而严格的封锁以及政府倾向于听取科学家的意见和实施广泛的测试制度似乎是成功的一部分。对测试的关注突出表明，需要使用可以可靠地检测到病毒的新型，高质量，快速分析方法。一个ffordable，s ^ ensitive，小号pecific，ü SER友好，[R APID和强大，ē quipment免费，并且d由世界卫生组织列出eliverable给最终用户）。传染性的样品，如含有SARS-CoV的-2，扩展到放心原则样品（其中R是- [R EAL时间连接和E是Ë样品收集的便利性）尤其重要。值得注意的是，COVID-19的新闻报道采用了曾经是分析化学领域的术语，成为了普通人群中的日常用语。突然，朋友和家人向我们询问测试率，吞吐量，误报，误报以及每种诊断测试的目的。同样，随着对COVID-19的新理解的发布，公众现在正在根据是否经过同行评审来审查信息及其可靠性。在分析化学和ACS传感器中，我们努力发表适合目标分析方法的论文，因此，我们认为我们发表的论文不仅对提出概念性进展的学术研究人员感兴趣，而且对寻求将诊断方法商业化的行业研究人员也很感兴趣方法。我们假设如果行业研究人员正在阅读《分析化学和ACS传感器》中的论文，那么人们也可以期望他们将在这些期刊上发表论文。公众意识到同行评审是质量的标志，这意味着一旦知识产权受到保护，高科技商业组织就会渴望发布。经过同行评审的公开研究确实是公司可获得的最佳广告文件之一。因此，问题是，基于行业的研究人员是否正在ACS传感器和分析化学中发表论文？？答案是肯定的，而且越来越多。在本期虚拟期刊中，我们展示了作者列表中最近与行业研究人员一起发表的一些优秀论文。在其中一些论文中，学术研究人员正在推动研究，而行业科学家作为中间作者则帮助指导研究。在其他论文中，行业研究人员是主要作者，有些论文的作者名单仅由基于行业的研究人员组成。我们见过的公司类型代表了最近发表在ACS传感器和分析化学上的论文从小型的大学创业公司到中小型企业再到大型跨国公司。科学本身也千差万别-从对侧向流动设备等著名传感概念的重大改进到全新的分析概念。这些论文的广度确实强调了对大学和工业界正在执行的诊断方法的令人难以置信的研究，并强调了两者之间合作的好处。随着政府开始考虑SARS-CoV-2后的经济复苏，这种合作似乎将成为我们未来的重要组成部分。有迹象表明，政府真的将推动更多的翻译研究和更多的本地（或主权）制造。从我们在ACS Sensors和在分析化学领域，我们看到行业做出的重大贡献使我们感到放心，我们发表的论文不仅鼓励行业研究人员阅读期刊，而且也鼓励他们发表期刊。本社论中表达的观点只是作者的观点，不一定是ACS的观点。本文尚未被其他出版物引用。